Progyny (NASDAQ: PGNY) reported Q4 EPS of $0.15, $0.11 better than the analyst estimate of $0.04. Revenue for the quarter came in at $127.6 million versus the consensus estimate of $136.08 million.

GUIDANCE:

Progyny sees Q1 2022 EPS of ($0.02)-($0.01), versus the consensus of $0.16. Progyny sees Q1 2022 revenue of $165-170 million, versus the consensus of $180.3 million.

Progyny sees FY2022 EPS of ($0.01)-$0.07, versus the consensus of $0.55. Progyny sees FY2022 revenue of $730-775 million, versus the consensus of $759 million.

For earnings history and earnings-related data on Progyny (PGNY) click here.